Table II.
Influence of different variables on cancer specific survival for patients with ES-SCLC analyzed by Cox proportional hazard model.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
Variable | χ2 | P-value | HR | 95% CI | P-value |
Age, years | 152.30 | <0.001 | <0.001 | ||
≤49 | Reference | ||||
50–64 | 1.093 | 0.966–1.236 | 0.158 | ||
≥65 | 1.378 | 1.220–1.555 | <0.001 | ||
Ethnicity | 12.70 | 0.002 | 0.006 | ||
White | Reference | ||||
Black | 0.954 | 0.877–1.038 | 0.274 | ||
Others | 0.814 | 0.714–0.928 | 0.002 | ||
Sex | 27.70 | <0.001 | <0.001 | ||
Male | Reference | ||||
Female | 0.890 | 0.849–0.934 | <0.001 | ||
AJCC T stage | 27.96 | <0.001 | 0.008 | ||
T1 | Reference | ||||
T2 | 1.142 | 1.037–1.258 | 0.007 | ||
T3 | 1.147 | 1.040–1.266 | 0.006 | ||
T4 | 1.150 | 1.050–1.260 | 0.003 | ||
AJCC N stage | 27.12 | <0.001 | 0.003 | ||
N0 | Reference | ||||
N1 | 0.953 | 0.848–1.071 | 0.417 | ||
N2 | 1.059 | 0.981–1.144 | 0.143 | ||
N3 | 0.973 | 0.891–1.062 | 0.533 | ||
Metastatic lesions | 78.73 | <0.001 | <0.001 | ||
1 | Reference | ||||
>1 | 1.237 | 1.178–1.299 | <0.001 | ||
Radiotherapy | 452.61 | <0.001 | <0.001 | ||
Yes | Reference | ||||
No | 1.591 | 1.513–1.672 | <0.001 |
ES-SCLC, extensive stage small cell lung cancer; HR, hazard ratio, CI, confidence interval; AJCC, American Joint Committee on Cancer; T, Tumor; N, Node.